Patient and tumor characteristics | N | Median (range) | p | N° positive cases (score >0) (%) | p |
---|---|---|---|---|---|
Total cases | 111 | 69 (0–288) | 83 (74.8) | ||
Age (years) | n.s. | n.s. | |||
≤ 58 | 55 | 68(0–279) | 44(80) | ||
>58 | 56 | 76(0–288) | 39(69.6) | ||
Menopausal status | n.s. | n.s. | |||
Premenopausal | 29 | 92(0–279) | 25(86.2) | ||
Postmenopausal | 82 | 59(2–288) | 58(70.4) | ||
Tumor size | n.s. | n.s. | |||
T1 | 50 | 80(0–288) | 40(80) | ||
T2 | 61 | 64(0–279) | 43(70.5) | ||
Nodal status | n.s. | n.s. | |||
Positive | 52 | 53(0–273) | 38(73.1) | ||
Negative | 59 | 100(0–288) | 45(76.3) | ||
Stage | n.s. | n.s. | |||
I | 32 | 71(0–273) | 25 (78.1) | ||
II | 51 | 64(0–243) | 40 (78.4) | ||
III | 28 | 83.5(0–288) | 18 (64.3) | ||
Histologic grade | n.s. | n.s. | |||
Well Dif. | 30 | 66.5(0–273) | 22(73.3) | ||
Mod. Dif. | 57 | 88(0–288) | 44(77.2) | ||
Poorly Dif. | 24 | 40.5(0–267) | 17(70.8) | ||
Estrogen receptor | n.s. | n.s. | |||
Negative | 52 | 55.5(0–273) | 34(65.4) | ||
Positive | 59 | 80(0–288) | 49(83.1) | ||
Progesterone receptor | n.s. | n.s. | |||
Negative | 59 | 58(0–279) | 41(69.5) | ||
Positive | 52 | 76(0–288) | 42(80.8) | ||
Desmoplastic reaction | n.s. | n.s. | |||
No | 35 | 48(0–270) | 23(65.7) | ||
Yes | 76 | 80.5(0–288) | 60(78.9) | ||
Peritumoral inflammation | n.s. | n.s. | |||
No | 65 | 69.5(0–279) | 48(75) | ||
Yes | 46 | 86(0–288) | 34(75.6) | ||
Tumor advancing edge | n.s. | n.s. | |||
Expansive | 49 | 50.5(0–270) | 33(68.8) | ||
Infiltrating | 62 | 84.5(0–288) | 48(80) | ||
Vascular invasion | n.s. | n.s. | |||
No | 72 | 64.5(0–288) | 52(72.2) | ||
Yes | 39 | 81(0–279) | 31(79.5) |